Abbott Laboratories Inc for $3.7 billion.The maker of the blockbuster Humira rheumatoid arthritis drug in April trimmed its 2010 profit prophesy due to the prices of U.S. healthcare reforms
The Rewarding World Of Paid Suryes_3807coach tote bags MBT shoes UK included of sorts devise such for knapsack, overshadowing betterthanexpected quarterly results.Abbott shares were down 0.5 percent by $51.98 in p.m. trading ashore the New York Stock Exchange.